Informations sur le produit
- Vyndaqel
- Fx 1006A
- D-Glucitol, 1-deoxy-1-(methylamino)-, 2-(3,5-dichlorophenyl)-6-benzoxazolecarboxylate (1:1)
Tafamidis meglumine is a drug that belongs to the class of drugs for treating cardiomyopathy. It is a prodrug of tafamidis which is hydrolyzed in vivo to its active form, tafamidis meglumine. Tafamidis meglumine has long-term efficacy and prevents the progression of heart failure by inhibiting the development of cardiac hypertrophy. This drug also has been shown to be effective against brain natriuretic peptides and other symptoms such as edema, anemia, and renal dysfunction. Tafamidis meglumine inhibits the activity of protein phosphatase 2A (PP2A), which dephosphorylates cardiac troponin I at serine residue 222. This leads to increased levels of troponin I, which induces apoptosis in cardiomyocytes.
Propriétés chimiques
Question d’ordre technique sur : 3D-FT159381 Tafamidis meglumine
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages
